Difference between revisions of "Part:BBa K3941002"

Line 25: Line 25:
 
<font size="-2"><b>Figure 2:</b> Schema of how did we designed our EGII (C99V)</font>
 
<font size="-2"><b>Figure 2:</b> Schema of how did we designed our EGII (C99V)</font>
  
We mutated the EGII to use and later on optimized it to use in <i>E. coli</i> DH5⍺ bacteria. We also used <i>E. coli</i> BL21 to express our plasmids. To harvest our proteins, we added a His-tag (6XHis) at the end of our AA sequence. We changed the Cystine from the 99th amino acid to Valine.
+
We mutated the EGII to use and later on optimized it to use in <i>E. coli</i> DH5⍺ bacteria. We also used <i>E. coli</i> BL21 to express our plasmids. To harvest our proteins, we added a His-tag (6XHis) at the end of our AA sequence. We changed the Cystine from the 99th amino acid to Valine. This mutation decreases the number of disulfide bonds. Decreasing the number of disulfide bonds increases the flexibility of protein and higher thermal stability.
  
  
Line 47: Line 47:
  
 
<font size="-2"><b>Figure 4:</b> The comparision between the backbone of the plasmid and EGII (C99V) is visible</font>
 
<font size="-2"><b>Figure 4:</b> The comparision between the backbone of the plasmid and EGII (C99V) is visible</font>
 +
 +
 +
 +
Lastly we conducted a CMCase Activity Analysis. EGII(C99V)  has an absorbance of 0,051 and enzyme activity of 2e-2 umol/L.min.
 +
 +
 +
https://2021.igem.org/wiki/images/b/b0/T--Saint_Joseph--Standard-Glucose-Calibration-Curve.png
 +
 +
<font size="-2"><b>Figure 5:</b> Calibration Curve for CMCase Activity Analysis</font>
 +
 +
 +
https://2021.igem.org/wiki/images/3/35/T--Saint_Joseph--EGII-C99V-absorbance_-values.png
 +
 +
<font size="-2"><b>Figure 6:</b> Graphs of EGII (C99V)'s CMCase Activity Analysis</font>
 +
 +
  
  

Revision as of 19:01, 17 October 2021


EGII (C99V)

BBa_K3941002 is a codon-optimized (for E. coli DH5⍺) C99V mutated version of the endoglucanase (EG) gene that cleaves the internal beta-1,4-glycosidic bonds in cellulose. We optimized the sequence for expression and added a 6XHis at the end.


800px-T--Saint_Joseph--Diagram-EGII-C99V.png

Figure 1: Codon optimized EGII with a C99V mutation and a His-Tag


Introduction EGII is produced by Trichoderma reesei which is a fungi. Substrate specificity, binding properties, and cleavage products of EGII were examined to evaluate its potential multiple enzymatic activities.


Design


799px-T--Saint_Joseph--Diagram-EGII-C99V-Design.png

Figure 2: Schema of how did we designed our EGII (C99V)

We mutated the EGII to use and later on optimized it to use in E. coli DH5⍺ bacteria. We also used E. coli BL21 to express our plasmids. To harvest our proteins, we added a His-tag (6XHis) at the end of our AA sequence. We changed the Cystine from the 99th amino acid to Valine. This mutation decreases the number of disulfide bonds. Decreasing the number of disulfide bonds increases the flexibility of protein and higher thermal stability.


Results

We have done a spectrophotometer absorbance analysis.


T--Saint_Joseph--Nanodrop-EGII-C99V.png

Figure 3: The results of spectrophotometer absorbance analysis. The numerical columns are A230, A260, A280, A320, A260/A280, A260/A230 respectively


After that we have done an agarose gel electrophoresis.


T--Saint_Joseph--Part-Agarose.png

Figure 4: The comparision between the backbone of the plasmid and EGII (C99V) is visible


Lastly we conducted a CMCase Activity Analysis. EGII(C99V) has an absorbance of 0,051 and enzyme activity of 2e-2 umol/L.min.


T--Saint_Joseph--Standard-Glucose-Calibration-Curve.png

Figure 5: Calibration Curve for CMCase Activity Analysis


T--Saint_Joseph--EGII-C99V-absorbance_-values.png

Figure 6: Graphs of EGII (C99V)'s CMCase Activity Analysis



Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]